ATR · Aptargroup, Inc.
$135.96
-0.79 (-0.58%)
At close · Aug 6
Market Cap
$8.69B
Shares
63.58M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Stephan Tanda | CEO | $7,018,822 |
| Robert Kuhn | CFO | $2,794,141 |
| Gael Touya | President of Aptar Pharma segment | $2,664,092 |
| Xiangwei Gong | President of Aptar Asia | $2,419,096 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Stephan Tanda | CEO | $7,918,040 |
| Robert Kuhn | CFO | $3,669,557 |
| Gael Touya | President of Aptar Pharma segment | $3,310,694 |
| Xiangwei Gong | President of Aptar Asia | $1,568,989 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Stephan Tanda | CEO | $8,039,185 |
| Robert Kuhn | CFO | $2,683,106 |
| Gael Touya | President of Aptar Pharma segment | $1,948,094 |
| Xiangwei Gong | President of Aptar Asia | $1,428,476 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Gael Touya | President and Chief Executive Officer | Appointed | 2026-03-17 |
| Stephan Tanda | President and Chief Executive Officer | Retired | 2026-03-17 |
| Stephan B. Tanda | director | Appointed | 2025-05-08 |
| Isabel Marey-Semper | director | Appointed | 2025-05-08 |
| Giovanna Kampouri Monnas | director | Appointed | 2025-05-08 |
| Daniel Ackerman | Chief Accounting Officer | Appointed | 2024-07-25 |
| Vanessa Kanu | Executive Vice President, Chief Financial Officer | Appointed | 2024-07-25 |
| Robert W. Kuhn | principal accounting officer | Retired | 2024-07-25 |
| Robert W. Kuhn | Executive Vice President, Chief Financial Officer | Retired | 2024-07-25 |
Key facts
CIK
896622
CUSIP
038336103
13F (30d)
225 filings
225 filers
Visit website
Investor relations